Financials
Financial year 2025
Dokter Sofie Van Binnebeek, Nucleaire geneeskunde from Huldenberg, company number BE0725867232, closed financial year 2025 with a result of € 241,147 after tax. For that financial year Dokter Sofie Van Binnebeek, Nucleaire geneeskunde recorded a gross margin of € 331,347 and equity of € 111,607. Compared with financial year 2024, the result moved from € 191,313 to € 241,147. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ 111,607
▼ 47% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 241,147
▲ 26% vs 2024
Profit after tax over the fiscal year.
€ 110,242
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 341,313 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 32,822
▼ 14% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 101
▼ 87% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 26,072
▲ € 20,673 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 230,723 | € 197,444 | € 261,022 | € 331,347 | ▲ 27% |
| Profit after taxes | € 170,097 | € 140,866 | € 191,313 | € 241,147 | ▲ 26% |
| Equity | € 294,735 | € 435,601 | € 211,773 | € 111,607 | ▼ 47% |
| Total debts | € 17,715 | € 56,772 | € 6,163 | € 176,172 | ▲ € 170,010 |
| Cash | € 204,678 | € 380,829 | € 104,168 | € 110,242 | ▲ 6% |
| Land & buildings | - | - | € 19,506 | € 19,506 | |
| Retained profit | € 276,135 | € 417,001 | € 191,313 | € 91,147 | ▼ 52% |
| Dividend | € 150,000 | € 0 | € 415,141 | € 341,313 | ▼ 18% |
| Balance sheet total | € 312,449 | € 492,373 | € 217,936 | € 287,779 | ▲ 32% |
Key figures of Dokter Sofie Van Binnebeek, Nucleaire geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dokter Sofie Van Binnebeek, Nucleaire geneeskunde?
What happened at Dokter Sofie Van Binnebeek, Nucleaire geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 241,147 (▲ 26% vs 2024). filed late Source: NBB ↗
- New establishment in Huldenberg. KBO
- Sofie Van Binnebeek became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 170,097 profit in 2022 to € 241,147 profit in 2025.
Paid € 245,676 in corporate taxes since 2022.
Best year ever: 2025, with € 241,147 profit.
Paid out € 906,454 in dividends to the owners in total.
Management
Behind Dokter Sofie Van Binnebeek, Nucleaire geneeskunde is Sofie Van Binnebeek.
Directors
According to the 2025 annual accounts
Sofie Van Binnebeek
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Kleinwaverstraat 50
3040 Huldenberg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0725.867.232
- VAT number
- BE 0725.867.232
- Registered office
- Kleinwaverstraat 50, 3040 Huldenberg
- Names & denominations
- Dokter Sofie Van Binnebeek, Nucleaire geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 2019
- Peppol
- Active · Active since 6 Jan 2026